Researcher.Life Logo

Gynecologic Oncology : Impact Factor & More

eISSN: 1095-6859pISSN: 0090-8258

Aims and Scope of Gynecologic Oncology

Gynecologic Oncology is a peer-reviewed medical journal covering all aspects of gynecologic oncology. The journal covers investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest. It is published by Elsevier and is the official journal of the Society of Gynecologic Oncology. Less

Key Metrics

CiteScore
7.4
Eigenfactor
0.01 - 0.05
H-Index
180
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
1.54
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gynecologic Oncology

Gynecologic Oncology Journal Specifications

Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gynecologic Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gynecologic Oncology

Real-world monitoring and clinical management of decreased platelet counts in patients with epithelial ovarian cancer who received first-line maintenance niraparib in the ACTIV1ZE study.
  • 1 Jun 2026
  • Gynecologic oncology
Impact of lymphadenectomy on survival outcomes for stage I malignant ovarian germ cell tumors.
  • 1 Jun 2026
  • Gynecologic oncology
Pathway-level somatic mutation burden reflects diffuse genomic accumulation rather than selective transcriptional disruption in ovarian serous carcinoma: Evidence from bulk, spatial, and multi-region genomic analyses.
  • 1 Jun 2026
  • Gynecologic oncology
Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers?
  • 1 Jun 2026
  • Gynecologic oncology
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.
  • 1 Jun 2026
  • Gynecologic oncology
Predictive features of anastomotic leakage after colorectal resection in complex multivisceral cytoreductive surgery for ovarian cancer.
  • 1 Jun 2026
  • Gynecologic oncology
Real-world monitoring and clinical management of decreased platelet counts in patients with epithelial ovarian cancer who received first-line maintenance niraparib in the ACTIV1ZE study.
  • 1 Jun 2026
  • Gynecologic oncology
Impact of lymphadenectomy on survival outcomes for stage I malignant ovarian germ cell tumors.
  • 1 Jun 2026
  • Gynecologic oncology
Pathway-level somatic mutation burden reflects diffuse genomic accumulation rather than selective transcriptional disruption in ovarian serous carcinoma: Evidence from bulk, spatial, and multi-region genomic analyses.
  • 1 Jun 2026
  • Gynecologic oncology
Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers?
  • 1 Jun 2026
  • Gynecologic oncology
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.
  • 1 Jun 2026
  • Gynecologic oncology
Predictive features of anastomotic leakage after colorectal resection in complex multivisceral cytoreductive surgery for ovarian cancer.
  • 1 Jun 2026
  • Gynecologic oncology

FAQs on Gynecologic Oncology